Sun Pharmaceutical Industries said that the company and certain subsidiaries have secured a favourable outcome in the long-running US antitrust litigation related to the 2008 Pfizer-Ranbaxy patent settlement for generic Lipitor (atorvastatin).
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.